Physician profile
Archana Gupta
NPI 1134475569
$2,674.12
in general payments reported to CMS, 2019-2025
20 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,284 · 2020: $38.25 · 2021: $60.75 · 2022: $526 · 2023: $266 · 2024: $278 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $746.43 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,069.33 | 2019-2024 | Rocklatan |
| New World Medical,INC. | $214.93 | 2022 | |
| Bausch & Lomb Americas INC. | $160.66 | 2023-2024 | Miebo, Xiidra, Ic-8 Apthera Iol |
| Carl Zeiss Meditec, INC. | $157.88 | 2019-2024 | |
| Biotissue Holdings INC. | $143.67 | 2021-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $143.62 | 2022-2023 | Tecnis Iol |
| Abbvie INC. | $123.71 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $111.94 | 2020-2023 | |
| Harrow Eye, LLC | $96.00 | 2025 | Vevye |
| Dompe US, INC. | $83.92 | 2022-2025 | Oxervate |
| Sight Sciences, INC. | $72.51 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Optovue, INC. | $65.51 | 2019 | |
| Allergan, INC. | $49.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $46.89 | 2022 | |
| Oyster Point Pharma, INC. | $44.81 | 2022-2023 | Tyrvaya |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $23.22 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $18.33 | 2024 | Xdemvy |
| Ocular Therapeutix, INC. | $15.62 | 2021 | |
| Horizon Therapeutics Plc | $13.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Archana Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.